Skip to main content
SpringerLink
Log in

TIE Receptors and Angiopoietins: Novel Modulators of Angiogenesis

  • Conference paper
Therapeutic Angiogenesis

Part of the book series: Ernst Schering Research Foundation Workshop 28 ((SCHERING FOUND,volume 28))

  • 48 Accesses

Abstract

“Angiogenesis” has perhaps become as popular a word as “Michael Jordan”, “Mickey Mouse”, or “Titanic” over the last few years. A Medline reference search shows an exponential increase of the publications in the field of angiogenesis: in 1970, a search using “angiogenesis” as a key word identified only one paper published. Similar searches identified 38 publications in 1980, 198 in 1990, and 839 in 1997. This clearly indicates the recognition of the field of angiogenesis as one of the most important biomedical fields.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Davis S, Aldrich TH, Jones PF, Acheson A, Bruno J, Radjiewski C, Compton D, Maisonpierre PC, Yancopoulos GD (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161–1169

    Article  PubMed  CAS  Google Scholar 

  • De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989–991

    Article  PubMed  Google Scholar 

  • Dumont DJ, Gradwohl GJ, Fong G-H, Auerbach R, Breitman ML (1993) The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene 8:1293–1301

    PubMed  CAS  Google Scholar 

  • Dumont DJ, Gradwohl G, Fong G-H, Puri MC, Gerstenstein M, Auerbach A, Breitman ML (1994) Domintant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculo-genesis of the embryo. Genes Dev 8:1897–1909

    Article  PubMed  CAS  Google Scholar 

  • Folkman J, D’Amore PA (1996) Blood vessel formation: what is its molecular basis? Cell 87:1153–1155

    Article  PubMed  CAS  Google Scholar 

  • Fong G-H, Rossant J, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulationg the assembly of vascular endothelium. Nature 376:66–70

    Article  PubMed  CAS  Google Scholar 

  • Fong G-H, Klingensmith J, Wood CR, Rossant J, Breitman ML (1996) Regulation of flt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium. Dev Dyn 207:1–10

    Article  PubMed  CAS  Google Scholar 

  • Hanahan D (1997) Signaling vascular morphogenesis and maintenance. Science 277:48–50

    Article  PubMed  CAS  Google Scholar 

  • Iwama A, Hamaguchi I, Hashiyama M, Murayama Y, Yasunaga K, Suda T (1993) Molecular cloning and characterization of mouse Tie and Tek receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun 195:301–309

    Article  PubMed  CAS  Google Scholar 

  • Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K(1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–298

    PubMed  CAS  Google Scholar 

  • Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang G-H, Dumont D, Breitman M, Alitalo K (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566–3570

    Article  PubMed  CAS  Google Scholar 

  • Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K (1992) Enhanced expression of the tie receptor tyrosine kinase in endlthelial cells during neovascularization. Blood 80:2548–2555

    PubMed  CAS  Google Scholar 

  • Lin P, Polverini P, Dewhirst M, Shan S, Rao PS, Peters K (1997) Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth. J Clin Invest 100:2072–2078

    Article  PubMed  CAS  Google Scholar 

  • Lin P, Buxton JA, Acheson A, Radziejewski C, Maisonpierre PC, Yancopoulos GD, Channon KM, Hale LP, Dewhirst MW, George SE, Peters KG (1998) Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase tie2. Proc Natl Acad Sci USA 95:8829–8834

    Article  PubMed  CAS  Google Scholar 

  • Maisonpierre PC, Goldfarb M, Yancopoulos GD, Gao G (1993) Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 8:1631–1637

    PubMed  CAS  Google Scholar 

  • Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadapoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2:a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60

    Article  PubMed  CAS  Google Scholar 

  • Millauer B, Wizigmann VS, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835–846

    Article  PubMed  CAS  Google Scholar 

  • Mustonen T, Alitalo K (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129:895–898

    Article  PubMed  CAS  Google Scholar 

  • Peters KG, Coogan A, Berry D, Marks J, Iglehart JD, Kontos CD, Rao P, Sankar S, Trogan E (1998) Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer 77:51–56

    Article  PubMed  CAS  Google Scholar 

  • Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J (1995) The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14:5884–5891

    PubMed  CAS  Google Scholar 

  • Quinn TP, Peters KG, De VC, Ferrara N, Williams LT (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90:7533–7537

    Article  PubMed  CAS  Google Scholar 

  • Sato TN, Qin Y, Kozak CA, Audus KL (1993) tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci USA 90:9355–9358

    Article  PubMed  CAS  Google Scholar 

  • Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70–74

    Article  PubMed  CAS  Google Scholar 

  • Schnurch H, Risau W (1993) Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 119:957–968

    PubMed  CAS  Google Scholar 

  • Shalaby F, Rossant J, Yamaguchi TP, Breitman M, Schuh AC (1995) Failure of blood island formation, vasculogenesis, and hematopoiesis in flk-1 deficient mice. Nature 376:62–66

    Article  PubMed  CAS  Google Scholar 

  • Shalaby F, Ho J, Stanford WL, Fischer K-D, Schuh AC, Schwartz L, Bernstein A, Rossant J (1997) A requirement for Flkl in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:981–990

    Article  PubMed  CAS  Google Scholar 

  • Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171–1180

    Article  PubMed  CAS  Google Scholar 

  • Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181–1190

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. T. N. Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

J. A. Dormandy W. P. Dole G. M. Rubanyi

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Sato, T.N. (1999). TIE Receptors and Angiopoietins: Novel Modulators of Angiogenesis. In: Dormandy, J.A., Dole, W.P., Rubanyi, G.M. (eds) Therapeutic Angiogenesis. Ernst Schering Research Foundation Workshop 28, vol 28. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03776-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-03776-8_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-03778-2

  • Online ISBN: 978-3-662-03776-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation